Host: Carol Wysham, MD Guest: Irl Hirsch, MD, MACP How is technology like continuous glucose monitors impacting the way we care for patients with diabetes, especially amid the COVID-19 pandemic? To learn more about the technological advancements in diabetes care, Dr. Carol Wysham speaks with Dr. Irl Hirsch, a Professor in Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine in Seattle, Washington. 

Diabetes Discourse

Improving Diabetes Care with Technology: A Look at Continuous Glucose Monitors

Host: Carol Wysham, MD Guest: Irl Hirsch, MD, MACP Why was there so much discordance between some patients’ GMI and their measured A1C? That’s the exact question Dr. Irl Hirsch from the University of Washington School of Medicine asked and explored in a paper he recently co-authored. And now Dr. Hirsch is here to share his findings.

Discovering the Discordance Between Measured A1Cs & GMIs

Host: John Buse, MD, PhD Guest: Anne Louise Peters, MD SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.

Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation

Host: John Buse, MD, PhD It can be tempting for patients to undermine the seriousness of diabetes. But in recognition of Diabetes Alert Day, Dr. John Buse explains why we need to set the record straight.

A Wake-Up Call to Diabetes: Spreading Awareness of Its Seriousness

Host: John Buse, MD, PhD How early should we start screening for diabetes, and what tools are available to us? In recognition of Diabetes Alert Day, Dr. John Buse reviews the current screening tests and recommendations for those who are at risk of diabetes.

When & How to Screen Patients for Diabetes

Host: John E. Anderson, MD Guest: Matthias Hebrok, PhD Emerging research may offer clinicians an alternative approach to treating type 1 diabetes. Dr. John Anderson meets with Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San Francisco, to discuss his groundbreaking research on insulin-producing stem cells.

Exploring Stem Cell Research & Novel Options in Diabetes

Host: John E. Anderson, MD Guest: Matthias Hebrok, PhD What are the effects of type 1 diabetes on the body? Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San Francisco shares some insight on type 1 diabetes and its chronic impact on patients.

Investigating Type 1 Diabetes & Its Chronic Impacts

Host: John Buse, MD, PhD Guest: Antonios Douros, MD Dr. John Buse joins Dr. Antonios Douros, Assistant Professor in the Department of Medicine at McGill University and research investigator at Lady Davis Institute in Montreal, Quebec, to discuss his latest research focusing on SGLT2 inhibitors and diabetic ketoacidosis risk.

Diving into Diabetes: Investigating SGLT2 Inhibitors & Diabetic Ketoacidosis

Host: Carol Wysham, MD Guest: Alexis Markey McKee, MD Patient care has evolved amid the COVID-19 pandemic, causing unexpected challenges in managing diseases such as diabetes. Dr. Carol Wysham joins Dr. Alexis McKee, a practicing endocrinologist and an assistant professor of medicine at Washington School of Medicine in St. Louis, Missouri, to discuss how patients have been overcoming challenges in managing diabetes during the pandemic.

Managing Diabetes During the COVID-19 Pandemic

Host: John Buse, MD, PhD Guest: David Wheeler, MB, CHB, MD, FRCP Recent research has revealed that a type 2 diabetes treatment may help manage chronic kidney disease. Dr. John Buse discusses the use of dapagliflozin in patients with chronic kidney disease with Dr. David Wheeler, a professor of kidney medicine at the University College London in the United Kingdom, and an honorary consultant nephrologist at the Royal Free London NHS Foundation Trust.

Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease

Host: Carol Wysham, MD Guest: Janet B. McGill, MD, MA, FACE, FACP Many patients with diabetes don’t fit into our stereotypes of type 1 or type 2 diabetes and identifying them is key to understanding how to treat them. Dr. Carol Wysham discusses atypical diabetes with Dr. Janet McGill, a professor of medicine at the Washington School of Medicine in St. Louis, Missouri.

Assessing Atypical Diabetes: Detection & Diagnosis

Host: John Anderson, MD Guest: Jason Sloane, MD There’s no denying that the COVID-19 pandemic has impacted every aspect of healthcare. So in an effort to recognize those who’ve gone above and beyond the call of duty, ReachMD’s Heroes in Healthcare initiative honors those healthcare professionals who were nominated by their peers for their outstanding contributions to the field of medicine. And one such nominee, Dr. Jason Sloane, joins Dr. John Anderson to discuss this nomination, strategies for optimal care, and his response to the COVID-19 pandemic.

Highlighting a Hero in Endocrinology: Dr. Jason Sloane

Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD The guidelines for healthy eating encourage a balance of many things, but doesn’t address the specific amount of carbohydrates, protein, and fat. And with so many fad diets circulating, how do we develop informed dietary recommendations for our patients with type 2 diabetes? Dr. Kathleen Stanley, a registered dietitian and certified diabetes educator with the Baptist Health Center discusses factors to take into consideration when making these decisions.

Fad Diets & Patients with Type 2 Diabetes

Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Physical activity is a valuable tool in treating patients with type 2 diabetes. But there are several factors clinicians must consider before prescribing exercise, including patient preference and limitations. Dr. John Anderson sits down with Dr. John Jackicic, Professor in the Department of Health and Physical Activity at the University of Pittsburgh, to discuss considerations when prescribing exercise to patients with type 2 diabetes.

Cardio Considerations: Individualized Exercise & Patients with Type 2 Diabetes

Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Exercise is an essential part of maintaining a healthy lifestyle, especially when managing a chronic condition such as type 2 diabetes. But what should we take into consideration when prescribing it? Dr. John Anderson is joined by Dr. John Jackicic, Professor in the Department of Health and Physical Activity at the University of Pittsburgh, to discuss exercise prescriptions for patients with type 2 diabetes.

Prescribing Exercise for Patients with Type 2 Diabetes

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.